Title:
Genetically engineered T cells could lead to therapies for autoimmune diseases
By:
University of Arizona
Published:
Medical Xpress, 3 December 2020
From the article:
A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.